Frequency and degree of aneuploidy in benign and malignant thyroid neoplasms.
The frequency and degree of aneuploidy in 44 benign and 124 malignant thyroid neoplasms were analyzed by DNA flow cytometry. Single aneuploid cell populations were found in 72% of the undifferentiated carcinomas, 64% of the follicular carcinomas, 24% of the papillary carcinomas and in 24% of the follicular adenomas. Multiple aneuploid cell populations were detected in 4% of the papillary and in 36% of the follicular carcinomas but not in undifferentiated carcinomas. A low degree of aneuploidy was found in well differentiated papillary carcinomas (mean DNA index of aneuploid populations: DI = 1.17; SD +/- 0.09). Significantly higher values were found for aneuploid moderately differentiated papillary carcinomas (DI = 1.46; SD +/- 0.29), well and moderately differentiated follicular carcinomas (DI = 1.61; SD +/- 0.33 and DI = 1.60; SD +/- 0.30, respectively) and undifferentiated carcinomas (DI = 1.72; SD +/- 0.19). High DNA indices were also found in several follicular adenomas (DI = 1.49; SD +/- 0.22). Comparison of the 10-year survival rates of patients with moderately versus well differentiated papillary carcinoma (79 vs. 98 months, respectively) indicates that loss of differentiation and progression of aneuploidy in this tumour type is associated with more aggressive clinical behaviour. Similarly, the high frequency and degree of aneuploidy in undifferentiated carcinomas is in agreement with the very poor survival rate (0% at 10 years) in this group of patients. However, the occurrence of highly aneuploid adenomas and (near)-diploid undifferentiated carcinomas does not point to a direct causal relationship between DNA-ploidy changes and clinical behaviour of these thyroid tumours.
Schelfhout
L J
LJ
Department of Pathology, State University Hospital, Leiden, The Netherlands.
Cornelisse
C J
CJ
Goslings
B M
BM
Hamming
J F
JF
Kuipers-Dijkshoorn
N J
NJ
van de Velde
C J
CJ
Fleuren
G J
GJ
D000230:Adenocarcinoma / Q000235:genetics* / Q000401:mortality; D000236:Adenoma / Q000235:genetics* / Q000401:mortality; D000782:Aneuploidy; D002277:Carcinoma / Q000235:genetics* / Q000401:mortality; D002291:Carcinoma, Papillary / Q000235:genetics* / Q000401:mortality; D004273:DNA, Neoplasm / Q000032:analysis; D005434:Flow Cytometry; D005500:Follow-Up Studies; D006801:Humans; D013964:Thyroid Neoplasms / Q000235:genetics* / Q000401:mortality
D004273:DNA, Neoplasm